D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population

Neuroscience Letters

Volumn 606, Issue , 2015, Pages 113-116

  Kalinderi, Kallirhoe ^a   Bostantjopoulou, Sevasti ^a   Katsarou, Zoe ^b   Dimikiotou, Maria ^a   Fidani, Liana ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University and Hippokration General Hospital   (Greece)

Author keywords

EIF4G1 gene; Mutation; Parkinson's disease; VPS35 gene

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; EUKARYOTIC TRANSLATION INITIATION FACTOR 4 GAMMA 1 GENE; GENE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VACUOLAR PROTEIN SORTING 35 GENE; CASE CONTROL STUDY; ETHNOLOGY; GENETICS; GREECE; MUTATION; VERY ELDERLY;

EIF4G1 PROTEIN, HUMAN; INITIATION FACTOR 4G; VESICULAR TRANSPORT PROTEIN; VPS35 PROTEIN, HUMAN;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUKARYOTIC INITIATION FACTOR-4G; GREECE; HUMANS; MUTATION; PARKINSON DISEASE; VESICULAR TRANSPORT PROTEINS;

EID: 84940829971     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.08.020     Document Type: Article

References (46)

1. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-535. Review.
2. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann. N.Y. Acad. Sci. 2003, 991:1-14.
3. Verstraeten A., Theuns J., Van Broeckhoven C. Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet. 2015, 31:140-149. Review.
4. Spatola M., Wider C. Genetics of Parkinson's disease: the yield. Parkinsonism Relat. Disord. 2014, 20(Suppl. 1):S35-S38. Review.
5. Vilariño-Güell C., Wider C., Ross O.A., Dachsel J.C., Kachergus J.M., Lincoln S.J., Soto-Ortolaza A.I., Cobb S.A., Wilhoite G.J., Bacon J.A., Behrouz B., Melrose H.L., Hentati E., Puschmann A., Evans D.M., Conibear E., Wasserman W.W., Aasly J.O., Burkhard P.R., Djaldetti R., Ghika J., Hentati F., Krygowska-Wajs A., Lynch T., Melamed E., Rajput A., Rajput A.H., Solida A., Wu R.M., Uitti R.J., Wszolek Z.K., Vingerhoets F., Farrer M.J. VPS35 mutations in Parkinson disease. Am. J. Hum. Genet. 2011, 89:162-167.
6. Zimprich A., Benet-Pagès A., Struhal W., Graf E., Eck S.H., Offman M.N., Haubenberger D., Spielberger S., Schulte E.C., Lichtner P., Rossle S.C., Klopp N., Wolf E., Seppi K., Pirker W., Presslauer S., Mollenhauer B., Katzenschlager R., Foki T., Hotzy C., Reinthaler E., Harutyunyan A., Kralovics R., Peters A., Zimprich F., Brücke T., Poewe W., Auff E., Trenkwalder C., Rost B., Ransmayr G., Winkelmann J., Meitinger T., Strom T.M. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 2011, 89:168-175.
7. Chartier-Harlin M.C., Dachsel J.C., Vilariño-Güell C., Lincoln S.J., Leprêtre F., Hulihan M.M., Kachergus J., Milnerwood A.J., Tapia L., Song M.S., Le Rhun E., Mutez E., Larvor L., Duflot A., Vanbesien-Mailliot C., Kreisler A., Ross O.A., Nishioka K., Soto-Ortolaza A.I., Cobb S.A., Melrose H.L., Behrouz B., Keeling B.H., Bacon J.A., Hentati E., Williams L., Yanagiya A., Sonenberg N., Lockhart P.J., Zubair A.C., Uitti R.J., Aasly J.O., Krygowska-Wajs A., Opala G., Wszolek Z.K., Frigerio R., Maraganore D.M., Gosal D., Lynch T., Hutchinson M., Bentivoglio A.R., Valente E.M., Nichols W.C., Pankratz N., Foroud T., Gibson R.A., Hentati F., Dickson D.W., Destée A., Farrer M.J. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am. J. Hum. Genet. 2011, 89:398-406.
8. Deng H., Gao K., Jankovic J. The VPS35 gene and Parkinson's disease. Mov. Disord. 2013, 28:569-575. Review.
9. Deng H., Wu Y., Jankovic J. The EIF4G1 gene and Parkinson's disease. Acta Neurol. Scand. 2015, (March 13). (Epub ahead of print).
10. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
11. Chen Y., Chen K., Song W., Chen X., Cao B., Huang R., Zhao B., Guo X., Burgunder J., Li J., Shang H.F. VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China. Neurobiol. Aging 2013, 34(1709). e7-8.
12. Zhang P., Yu L., Gao J., Fu Q., Dai F., Zhao Y., Zheng L., Zhao S. Cloning and characterization of human VPS35 and mouse Vps35 and mapping of VPS35 to human chromosome 16q13-q21. Genomics 2000, 70:253-257.
13. Attar N., Cullen P.J. The retromer complex. Adv. Enzyme Regul. 2010, 50:216-236.
14. Follett J., Norwood S.J., Hamilton N.A., Mohan M., Kovtun O., Tay S., Zhe Y., Wood S.A., Mellick G.D., Silburn P.A., Collins B.M., Bugarcic A., Teasdale R.D. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer. Traffic 2014, 15:230-244.
15. Munsie L.N., Milnerwood A.J., Seibler P., Beccano-Kelly D.A., Tatarnikov I., Khinda J., Volta M., Kadgien C., Cao L.P., Tapia L., Klein C., Farrer M.J. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutationD620N. Hum. Mol. Genet. 2015, 24:1691-1703.
16. Cullen V., Lindfors M., Ng J., Paetau A., Swinton E., Kolodziej P., Boston H., Saftig P., Woulfe J., Feany M.B., Myllykangas L., Schlossmacher M.G., Tyynelä J. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol. Brain 2009, 2:1756-6606.
17. Miura E., Hasegawa T., Konno M., Suzuki M., Sugeno N., Fujikake N., Geisler S., Tabuchi M., Oshima R., Kikuchi A., Baba T., Wada K., Nagai Y., Takeda A., Aoki M. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease. Neurobiol. Dis. 2014, 71:1-13.
18. Tsika E., Glauser L., Moser R., Fiser A., Daniel G., Sheerin U.M., Lees A., Troncoso J.C., Lewis P.A., Bandopadhyay R., Schneider B.L., Moore D.J. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Hum. Mol. Genet. 2014, 23:4621-4638.
19. Wang H.S., Toh J., Ho P., Tio M., Zhao Y., Tan E.K. In vivo evidence of pathogenicity of VPS35 mutations in the Drosophila. Mol. Brain 2014, 7:73.
20. Zavodszky E., Seaman M.N., Moreau K., Jimenez-Sanchez M., Breusegem S.Y., Harbour M.E., Harbour M.E., Rubinsztein D.C. Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy. Nat. Commun. 2014, 5:3828.
21. Edvardson S., Cinnamon Y., Ta-Shma A., Shaag A., Yim Y.I., Zenvirt S., Jalas C., Lesage S., Brice A., Taraboulos A., Kaestner K.H., Greene L.E., Elpeleg O. A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile Parkinsonism. PLoS One 2012, 7:e36458.
22. Vilariño-Güell C., Rajput A., Milnerwood A.J., Shah B., Szu-Tu C., Trinh J., Yu I., Encarnacion M., Munsie L.N., Tapia L., Gustavsson E.K., Chou P., Tatarnikov I., Evans D.M., Pishotta F.T., Volta M., Beccano-Kelly D., Thompson C., Lin M.K., Sherman H.E., Han H.J., Guenther B.L., Wasserman W.W., Bernard V., Ross C.J., Appel-Cresswell S., Stoessl A.J., Robinson C.A., Dickson D.W., Ross O.A., Wszolek Z.K., Aasly J.O., Wu R.M., Hentati F., Gibson R.A., McPherson P.S., Girard M., Rajput M., Rajput A.H., Farrer M.J. DNAJC13 mutations in Parkinson disease. Hum. Mol. Genet. 2014, 23:1794-1801.
23. Krebs C.E., Karkheiran S., Powell J.C., Cao M., Makarov V., Darvish H., Di Paolo G., Walker R.H., Shahidi G.A., Buxbaum J.D., De Camilli P., Yue Z., Paisán-Ruiz C. The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive parkinsonism with generalized seizures. Hum. Mutat. 2013, 34:1200-1207.
24. Quadri M., Fang M., Picillo M., Olgiati S., Breedveld G.J., Graafland J., Wu B., Xu F., Erro R., Amboni M., Pappatà S., Quarantelli M., Annesi G., Quattrone A., Chien H.F., Barbosa E.R., Oostra B.A., Barone P., Wang J., Bonifati V., International P., arkinsonism G., enetics N., etwork Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. Hum. Mutat. 2013, 34:1208-1215.
25. Perrett R.M., Alexopoulou Z., Tofaris G.K. The endosomal pathway in Parkinson's disease. Mol. Cell. Neurosci. 2015, 66:21-28.
26. Piccoli G., Condliffe S.B., Bauer M., Giesert F., Boldt K., De Astis S., Meixner A., Sarioglu H., Vogt-Weisenhorn D.M., Wurst W., Gloeckner C.J., Matteoli M., Sala C., Ueffing M. LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J. Neurosci. 2011, 31:2225-2237.
27. MacLeod D.A., Rhinn H., Kuwahara T., Zolin A., Di Paolo G., McCab B.D., Marder K.S., Honig L.S., Clark L.N., Small S.A., Abeliovich A. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 2013, 77:425-439.
28. Tucci A., Nalls M.A., Houlden H., Revesz T., Singleton A.B., Wood N.W., Hardy J., Paisán-Ruiz C. Genetic variability at the PARK16 locus. Eur. J. Hum. Genet. 2010, 18:1356-1359.
29. Linhart R., Wong S.A., Cao J., Tran M., Huynh A., Ardrey C., Park J.M., Hsu C., Taha S., Peterson R., Shea S., Kurian J., Venderova K. Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2). Mol. Neurodegener. 2014, 9:23.
30. Nj M., Seaman C.L.F. Analysis of the retromer complex-WASH complex interaction illuminates new avenues to explore in Parkinson disease. Commun. Integr. Biol. 2014, 7:e29483.
31. Yan R., Rhoads R.E. Human protein synthesis initiation factor eIF-4 is encoded by a single gene (EIF4G) that maps to chromosome 3q27-qter. Genomics 1995, 26:394-398.
32. Sonenberg N., Hinnebusch A.G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009, 136:731-745.
33. Gehrke S., Imai Y., Sokol N., Lu B. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 2010, 466:637-641.
34. Dhungel N., Eleuteri S., Li L., Kramer N.J., Chartron J.W., Spencer B., Kosberg K., Fields J.A., Stafa K., Adame A., Lashuel H., Frydman J., Shen K., Masliah E., Gitler A.D. Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein. Neuron 2015, 85:76-87.
35. Kara E., Xiromerisiou G., Spanaki C., Bozi M., Koutsis G., Panas M., Dardiotis E., Ralli S., Bras J., Letson C., Edsall C., Pliner H., Arepalli S., Kalinderi K., Fidani L., Bostantjopoulou S., Keller M.F., Wood N.W., Hardy J., Houlden H., Stefanis L., Plaitakis A., Hernandez D., Hadjigeorgiou G.M., Nalls M.A., Singleton A.B. Assessment of Parkinson's disease risk loci in Greece. Neurobiol. Aging 2014, 35(442). e9-442. e16.
36. Guo J.F., Sun Q.Y., Lv Z.Y., Yu R.L., Li K., Zhang Y.H., Tian J.Y., Xia K., Yan X.X., Tang B.S. VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population. Parkinsonism Relat. Disord. 2012, 18:983-985.
37. Zhang Y., Chen S., Xiao Q., Cao L., Liu J., Rong T.Y., Ma J.F., Wang G., Wang Y., Chen S.D. Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease. Parkinsonism Relat. Disord. 2012, 18:638-640.
38. Verstraeten A., Wauters E., Crosiers D., Meeus B., Corsmit E., Elinck E., Mattheijssens M., Peeters K., Cras P., Pickut B., Vandenberghe R., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Theuns J. Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population. Neurobiol. Aging 2012, 33(1844). e11-3.
39. Blanckenberg J., Ntsapi C., Carr J.A., Bardien S. EIF4G1 R1205H and VPS D620N mutations are rare in Parkinson's disease from South Africa. Neurobiol. Aging 2014, 35(445). e1-3.
40. Sudhaman S., Behari M., Govindappa S.T., Muthane U.B., Juyal R.C., Thelma B.K. VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians. Neurobiol. Aging 2013, 34(2442). e1-3.
41. Nichols N., Bras J.M., Hernandez D.G., Jansen I.E., Lesage S., Lubbe S., Singleton A.B., International Parkinson's Disease Genomics Consortium EIF4G1 mutations do not cause Parkinson's disease. Neurobiol. Aging 2015, 4(2444). e1-4.
42. Deng H., Xu H., Deng X., Song Z., Zheng W., Gao K., Fan X., Tang J. VPS35 mutation in Chinese Han patients with late-onset Parkinson's disease. Eur. J. Neurol. 2012, 19:e96-e97.
43. Nuytemans K., Bademci G., Inchausti V., Dressen A., Kinnamon D.D., Mehta A., Wang L., Züchner S., Beecham G.W., Martin E.R., Scott W.K., Vance J.M. Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease. Neurology 2013, 80:982-989.
44. Sheerin U.M., Charlesworth G., Bras J., Guerreiro R., Bhatia K., Foltynie T., Limousin P., Silveira-Moriyama L., Lees A., Wood N. Screening for VPS35 mutations in Parkinson's disease. Neurobiol. Aging 2012, 33(838). e1-5.
45. Yuan L., Song Z., Xu H., Gu S., Zhu A., Gong L., Zhao Y., Deng H. EIF4G1 Ala502Val and Arg1205His variants in Chinese patients with Parkinson disease. Neurosci. Lett. 2013, 543:69-71.
46. Kumar K.R., Weissbach A., Heldmann M., Kasten M., Tunc S., Sue C.M., Svetel M., Kostić V.S., Segura-Aguilar J., Ramirez A., Simon D.K., Vieregge P., Münte T.F., Hagenah J., Klein C., Lohmann K. Frequency of the D620N mutation in VPS35 in Parkinson disease. Arch. Neurol. 2012, 69:1360-1364.